Skip to main content

Table 3 Cell apoptosis after bortezomib treatment

From: Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1–Survivin axis

Cell line Group Cell apoptosis rate (%)
Total Early-stage Late-stage
U251 Control 5.78 ± 1.34 2.56 ± 0.44 3.22 ± 0.26
10 nmol/L Bor 14.01 ± 1.33 5.68 ± 1.42 8.33 ± 1.51
20 nmol/L Bor 23.07 ± 3.21 13.49 ± 1.97 9.58 ± 2.50
U87 Control 11.62 ± 2.12 6.02 ± 1.08 5.58 ± 1.86
10 nmol/L Bor 28.03 ± 31.34 21.08 ± 1.52 6.95 ± 0.21
20 nmol/L Bor 41.17 ± 2.55 31.48 ± 2.97 10.23 ± 0.93